Table 3. Correlation of the PI3K/AKT/mTOR mRNA expression with OS in different sex of ccRCC patients (K-M plotter, n = 530).
| Gene | Sex | n | HR (95% CI) | P-value |
|---|---|---|---|---|
| PTEN | female | 186 | 0.35 (0.21–0.59) | <0.001 |
| male | 344 | 0.53 (0.36–0.77) | <0. 001 | |
| PIK3CA | female | 186 | 0.27 (0.15–0.51) | <0. 001 |
| male | 344 | 0.57 (0.39–0.82) | 0.003 | |
| PIK3CB | female | 186 | 0.45 (0.27–0.76) | 0.002 |
| male | 344 | 0.48 (0.33–0.70) | <0.001 | |
| PIK3CD | female | 186 | 0.57 (0.34–0.97) | 0.037 |
| male | 344 | 1.81 (1.22–2.68) | 0.003 | |
| PIK3CG | female | 186 | 0.49 (0.30–0.82) | 0.006 |
| male | 344 | 0.68 (0.47–0.99) | 0.044 | |
| AKT1 | female | 186 | 0.51 (0.31–0.85) | 0.008 |
| male | 344 | 0.76 (0.49–1.17) | 0.210 | |
| AKT2 | female | 186 | 0.76 (0.46–1.25) | 0.270 |
| male | 344 | 1.71 (1.15–2.55) | 0.007 | |
| AKT3 | female | 186 | 0.32 (0.20–0.54) | <0.001 |
| male | 344 | 0.48 (0.31–0.72) | <0.001 | |
| mTOR | female | 186 | 0.27 (0.14–0.52) | <0.001 |
| male | 344 | 0.78 (0.54–1.14) | 0.200 |